SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
43.18 EUR
-0.14 (-0.32%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 60 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
In the past 5 years SHL has always been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of SHL (4.87%) is better than 68.33% of its industry peers.
Looking at the Return On Equity, with a value of 12.29%, SHL is in the better half of the industry, outperforming 76.67% of the companies in the same industry.
SHL has a better Return On Invested Capital (7.89%) than 73.33% of its industry peers.
SHL had an Average Return On Invested Capital over the past 3 years of 5.87%. This is below the industry average of 8.99%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
SHL has a better Profit Margin (9.29%) than 70.00% of its industry peers.
In the last couple of years the Profit Margin of SHL has declined.
With a decent Operating Margin value of 13.76%, SHL is doing good in the industry, outperforming 68.33% of the companies in the same industry.
SHL's Operating Margin has declined in the last couple of years.
SHL's Gross Margin of 38.76% is on the low side compared to the rest of the industry. SHL is outperformed by 75.00% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SHL has more shares outstanding than it did 1 year ago.
SHL has more shares outstanding than it did 5 years ago.
SHL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.01 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.01 is in line compared to the rest of the industry. SHL outperforms 50.00% of its industry peers.
The Debt to FCF ratio of SHL is 5.10, which is a neutral value as it means it would take SHL, 5.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SHL (5.10) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.66 indicates that SHL is somewhat dependend on debt financing.
The Debt to Equity ratio of SHL (0.66) is worse than 71.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.01 |
ROIC/WACC1.33
WACC5.93%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL has a Current ratio of 1.12. This is in the lower half of the industry: SHL underperforms 70.00% of its industry peers.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a Quick ratio of 0.77. This is in the lower half of the industry: SHL underperforms 71.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.85%.
Measured over the past years, SHL shows a quite strong growth in Revenue. The Revenue has been growing by 9.02% on average per year.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.14% on average over the next years.
EPS Next Y8.04%
EPS Next 2Y6.98%
EPS Next 3Y8.82%
EPS Next 5Y10.57%
Revenue Next Year4.87%
Revenue Next 2Y4.54%
Revenue Next 3Y5.03%
Revenue Next 5Y6.14%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.14 indicates a rather expensive valuation of SHL.
SHL's Price/Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.91. SHL is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.92, which indicates a correct valuation of SHL.
65.00% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
SHL is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.14 | ||
| Fwd PE | 16.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than 63.33% of the companies in the same industry.
SHL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SHL is cheaper than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.83 | ||
| EV/EBITDA | 13.97 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.26
PEG (5Y)2.5
EPS Next 2Y6.98%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.14%.
Compared to an average industry Dividend Yield of 2.37, SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.08% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y6.98%
EPS Next 3Y8.82%
FRA:SHL (11/14/2025, 9:22:08 AM)
43.18
-0.14 (-0.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.71B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts82.96
Price Target60.62 (40.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.14% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)-2.04%
PT rev (3m)-1.94%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-4.91%
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.14 | ||
| Fwd PE | 16.92 | ||
| P/S | 2.08 | ||
| P/FCF | 15.83 | ||
| P/OCF | 12.66 | ||
| P/B | 2.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.97 |
EPS(TTM)2.38
EY5.51%
EPS(NY)2.55
Fwd EY5.91%
FCF(TTM)2.73
FCFY6.32%
OCF(TTM)3.41
OCFY7.9%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.26
PEG (5Y)2.5
Graham Number28.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.01 |
F-Score8
WACC5.93%
ROIC/WACC1.33
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y8.04%
EPS Next 2Y6.98%
EPS Next 3Y8.82%
EPS Next 5Y10.57%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.87%
Revenue Next 2Y4.54%
Revenue Next 3Y5.03%
Revenue Next 5Y6.14%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.88%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 18.14 and the Price/Book (PB) ratio is 2.76.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.08%.